logo

For the Inventor, By the Inventor

Andover, MA, United States of America

Deuterx, LLC


USPTO Granted Patents = 23

% Expired Patents = 8.7



Forward Citations = 358

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Sheila DeWitt (14 out of 21 patents)

silverMedal Anthony W Czarnik (6 out of 32 patents)

bronzeMedal Vincent Jacques (5 out of 30 patents)

4.  Leonardus H T Van Der Ploeg (2 out of 32 patents)

5.  William Perrault (1 out of 1 patent)

6.  Leonardus Van Der Ploeg (4 patents)

7.  Sheila Dewitt (0 patent)


23 patents:

1. 12180137 - Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof (2024-12-31),
2. 11535603 - Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same (2022-12-27),
3. 11491156 - 3-(substituted-4-oxoquinazolin-3(4)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same (2022-11-08),
4. 11040925 - 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same (2021-06-22),
5. 10555946 - 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same (2020-02-11),
6. 10202316 - 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same (2019-02-12),
7. 10189858 - Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same (2019-01-29),
8. 10188639 - Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone (2019-01-29),
9. 9925175 - Deuterium-enriched pioglitazone (2018-03-27),
10. 9913845 - 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same (2018-03-13),
11. 9833445 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same (2017-12-05),
12. 9809603 - Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same (2017-11-07),
13. 9732031 - Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion (2017-08-15),
14. 9540340 - [object Object] (2017-01-10),
15. 9416117 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same (2016-08-16),
Deuterx, LLC, based in Andover, MA, specializes in the development of advanced biopharmaceuticals, focusing on innovative therapies that leverage deuterated compounds. The company is dedicated to enhancing drug efficacy and safety through its proprietary technology, which modifies molecular structures to improve pharmacological properties. With a commitment to research and development, Deuterx aims to address unmet medical needs across various therapeutic areas, contributing to the advancement of healthcare solutions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Deuterx, LLC
23 Patents

#13 in Andover, MA

#863 in Massachusetts

#14,401 in US

#27,619 in the World

Andover, MA (US)
Andover, MA, United States of America

Deuterx, LLC

Forward Citations = 358

5 inventors:

goldMedal Sheila DeWitt (14 out of 21 patents)

silverMedal Anthony W Czarnik (6 out of 32 patents)

bronzeMedal Vincent Jacques (5 out of 30 patents)

4.  Leonardus H T Van Der Ploeg (2 out of 32 patents)

5.  William Perrault (1 out of 1 patent)

Please report any incorrect information to [email protected]
Loading…